How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

2,018 results for

Cholesterol Education Resources

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

41. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia

of economic evaluation Cost-effectiveness analysis, cost-utility analysis Study objective This study assessed the cost-effectiveness of guidelines for the prevention of coronary heart disease (CHD) by reducing cholesterol and triglycerides in a typical 60-year-old patient with diabetes mellitus and mixed dyslipidaemia. Interventions The National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) guidelines were compared with the usual care. These guidelines had the following target (...) Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia Model-based simulation to explore the cost-effectiveness

2009 NHS Economic Evaluation Database.

42. Telemedicine Strategy With Home Treatment Save Resources

Telemedicine Strategy With Home Treatment Save Resources Telemedicine Strategy With Home Treatment Save Resources - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Telemedicine Strategy With Home Treatment (...) Save Resources The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02214017 Recruitment Status : Completed First Posted : August 12, 2014 Results First Posted : November 19, 2018 Last Update Posted : November 19, 2018 Sponsor: Kolding Sygehus Information provided by (Responsible Party): Ole Winther

2014 Clinical Trials

43. Effects of a Supplement Derived From Palm Oil on Cholesterol Levels and Chinese Red Yeast Rice in the Blood

Criteria Inclusion Criteria: Able to read and understand English Male or female, 35-70 years old (inclusive) Total Fasting Plasma Cholesterol of 200 to 240 mg/dl Willing to maintain American heart Association (AHA) Step 1 diet for the duration of the study. Agree to abstain from consuming large amounts of grapefruit juice for the duration of the study. Exclusion Criteria: Any subject with an National Cholesterol Education Program (NCEP) 10-year cardiovascular (CV) risk > 10% will be excluded. Women who (...) Effects of a Supplement Derived From Palm Oil on Cholesterol Levels and Chinese Red Yeast Rice in the Blood Effects of a Supplement Derived From Palm Oil on Cholesterol Levels and Chinese Red Yeast Rice in the Blood - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies

2014 Clinical Trials

44. Cutaneous Manifestations of Cholesterol Embolism (Overview)

rate within 15 months. Those who survive may be left with chronic renal insufficiency requiring hemodialysis, [ ] stroke resulting in paraplegia, unstable angina, amputation of the affected extremity (5-15% of patients), and malnutrition or significant weight loss (70% of patients). Previous Next: Patient Education For excellent patient education resources, visit eMedicineHealth's . Also, see eMedicineHealth's patient education articles , , and . Previous References Fine MJ, Kapoor W, Falanga V (...) Cutaneous Manifestations of Cholesterol Embolism (Overview) Cutaneous Manifestations of Cholesterol Embolism: Background, Pathophysiology, Epidemiology Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache

2014 eMedicine.com

45. Cutaneous Cholesterol Emboli (Overview)

is a repetitive process. Untreated patients often have recurrent episodes with significant morbidity and mortality; however, patients with only peripheral involvement, as opposed to both peripheral and visceral involvement, have a much better prognosis. In the most extensive review of CCE cases, the mortality rate was very high. Forty-nine (78%) of 68 patients died. Previous Next: Patient Education For patient education resources, see the , , and , as well as , , and . Previous References Muehlenberg K (...) Cutaneous Cholesterol Emboli (Overview) Cutaneous Cholesterol Emboli: Background, Pathophysiology, Etiology Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTA5NTk2OS1vdmVydmlldw== processing > Cutaneous

2014 eMedicine.com

46. Low LDL Cholesterol (Hypobetalipoproteinemia) (Follow-up)

. [ ] Nutritional counseling should include dietary recommendations for a low-fat diet (low in long-chain fatty acids) and advice to take prescribed vitamins as directed. For excellent patient education resources, visit eMedicineHealth's . Also, see the eMedicineHealth's patient education articles and . Previous References Welty FK. Hypobetalipoproteinemia and abetalipoproteinemia. Curr Opin Lipidol . 2014 Jun. 25(3):161-8. . Sen D, Dagdelen S, Erbas T. Hepatosteatosis with hypobetalipoproteinemia. J Natl Med (...) Low LDL Cholesterol (Hypobetalipoproteinemia) (Follow-up) Low LDL Cholesterol (Hypobetalipoproteinemia) Follow-up: Further Outpatient Care, Further Inpatient Care, Inpatient & Outpatient Medications Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache

2014 eMedicine.com

47. Low HDL Cholesterol (Hypoalphalipoproteinemia) (Follow-up)

from the development of complications. Previous Next: Patient Education See the list below: Pursue aggressive dietary modification. Discuss medications and their potential adverse effects, and monitor for adverse effects. For excellent patient education resources, visit eMedicineHealth's . Also, see eMedicineHealth's patient education articles , , , and . Previous References Yamakawa-Kobayashi K, Yanagi H, Fukayama H, et al. Frequent occurrence of hypoalphalipoproteinemia due to mutant (...) apolipoprotein A-I gene in the population: a population-based survey. Hum Mol Genet . 1999 Feb. 8(2):331-6. . . Gebauer SK, Destaillats F, Dionisi F, Krauss RM, Baer DJ. Vaccenic acid and trans fatty acid isomers from partially hydrogenated oil both adversely affect LDL cholesterol: a double-blind, randomized controlled trial. Am J Clin Nutr . 2015 Nov 11. . Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High

2014 eMedicine.com

48. High HDL Cholesterol (Hyperalphalipoproteinemia) (Follow-up)

. If appropriate, the consequences of excessive alcohol intake must be discussed. For excellent patient education resources, see eMedicineHealth's patient education articles , , , and . Previous References Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation . 1989 Jan. 79 (1):8-15. . Marz W, Kleber ME, Scharnagl H, et al. HDL cholesterol: reappraisal of its clinical relevance. Clin Res Cardiol . 2017 Sep (...) . 106 (9):663-75. . . Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA . 2001 May 16. 285(19):2486-97. . Mora S, Buring JE, Ridker PM, Cui Y. Association of high-density lipoprotein cholesterol with incident cardiovascular events in women, by low-density lipoprotein cholesterol and apolipoprotein b100 levels: a cohort study. Ann Intern

2014 eMedicine.com

49. Cutaneous Manifestations of Cholesterol Embolism (Diagnosis)

rate within 15 months. Those who survive may be left with chronic renal insufficiency requiring hemodialysis, [ ] stroke resulting in paraplegia, unstable angina, amputation of the affected extremity (5-15% of patients), and malnutrition or significant weight loss (70% of patients). Previous Next: Patient Education For excellent patient education resources, visit eMedicineHealth's . Also, see eMedicineHealth's patient education articles , , and . Previous References Fine MJ, Kapoor W, Falanga V (...) Cutaneous Manifestations of Cholesterol Embolism (Diagnosis) Cutaneous Manifestations of Cholesterol Embolism: Background, Pathophysiology, Epidemiology Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache

2014 eMedicine.com

50. Cutaneous Cholesterol Emboli (Diagnosis)

is a repetitive process. Untreated patients often have recurrent episodes with significant morbidity and mortality; however, patients with only peripheral involvement, as opposed to both peripheral and visceral involvement, have a much better prognosis. In the most extensive review of CCE cases, the mortality rate was very high. Forty-nine (78%) of 68 patients died. Previous Next: Patient Education For patient education resources, see the , , and , as well as , , and . Previous References Muehlenberg K (...) Cutaneous Cholesterol Emboli (Diagnosis) Cutaneous Cholesterol Emboli: Background, Pathophysiology, Etiology Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTA5NTk2OS1vdmVydmlldw== processing > Cutaneous

2014 eMedicine.com

51. Cholesterol Embolism (Overview)

insults occur, even to the point where dialysis can be discontinued. However, patients remain at risk for recurrence of emboli. Previous Next: Patient Education Patients should be educated to watch for ulcerations and infections in chronically ischemic areas, particularly feet and toes. Ischemic neuropathy may exacerbate injury and tissue loss, predisposing the patient to gangrene. For patient education resources, see the , as well as , , , and . Previous References Li X, Bayliss G, Zhuang S (...) Cholesterol Embolism (Overview) Cholesterol Embolism: Background, Pathophysiology, Etiology Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvNDYwNDI4LW92ZXJ2aWV3 processing > Cholesterol Embolism Updated: Oct 05

2014 eMedicine Surgery

52. Cholesterol Embolism (Diagnosis)

insults occur, even to the point where dialysis can be discontinued. However, patients remain at risk for recurrence of emboli. Previous Next: Patient Education Patients should be educated to watch for ulcerations and infections in chronically ischemic areas, particularly feet and toes. Ischemic neuropathy may exacerbate injury and tissue loss, predisposing the patient to gangrene. For patient education resources, see the , as well as , , , and . Previous References Li X, Bayliss G, Zhuang S (...) Cholesterol Embolism (Diagnosis) Cholesterol Embolism: Background, Pathophysiology, Etiology Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvNDYwNDI4LW92ZXJ2aWV3 processing > Cholesterol Embolism Updated: Oct 05

2014 eMedicine Surgery

53. Effect of Alirocumab on Lipid Metabolism in Adults With Elevated LDL-Cholesterol

: Single (Participant) Primary Purpose: Basic Science Official Title: A Phase 1 Study of the Effects of Subcutaneous Doses of Alirocumab on Lipid and Lipoprotein Metabolism in Adults With Mildly Elevated LDL-Cholesterol Study Start Date : December 2013 Actual Primary Completion Date : May 2015 Actual Study Completion Date : May 2015 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Experimental: Placebo (...) . Exclusion criteria: LDL-C ≥ 160 mg/dL at Screening if more than 2 major Coronary Heart Disease risk factors, as defined in National Cholesterol Education Program guidelines. Receiving treatment of any kind for hyperlipidemia within 6 weeks of enrollment. The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial. Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you

2013 Clinical Trials

54. The irony of how my state medical association spends resources

The irony of how my state medical association spends resources The state of health care in America: Smell the bacon The state of health care in America: Smell the bacon | | May 19, 2016 45 Shares I am forced to attend one of these mandatory continuing medical education (CME) events. My malpractice insurance provider has a deal with the state medical association. To get lower rates, I have to be a member of the association and every 2 or 3 years attend a risk management training session. I make (...) our advanced risk management training. The room is finishing the supplied “advanced risk” high saturated animal fat and cholesterol breakfast managing further disease-causing inflammation, plaque build up, and carcinogen load. We are introduced to the 3 speakers/panelists up front and 4 to 5 insurance company people sitting around me, including the well-dressed bacon lady. The course is presented by a retired doctor and an attorney. “Why are all these other highly-paid insurance company people

2016 KevinMD blog

55. Image of the Week: Pure Cholesterol Crystal

, into low-density lipoprotein cholesterol in the blood. ‘Big Picture’ is a free and impartial educational resource that explores the innovations and implications of cutting-edge science. Our gets to grips with the greasy world of fats and lipids to find out what they do, not just inside us and other organisms but also in the world around us. is one of the world’s richest and most unusual collections, with themes ranging from medical and social history to contemporary healthcare and Share this post: Like (...) Image of the Week: Pure Cholesterol Crystal Image of the Week: Pure Cholesterol Crystal | Wellcome Trust Blog Life from a Wellcome Trust perspective Image of the Week: Pure Cholesterol Crystal 8 Jan, 2016 tags: , , , , , by It’s the New Year which means lots of discussions about resolutions and healthy living, whether that’s pledging to exercise more often or cutting back on fatty foods. With this in mind our image of the week is from our latest issue of which is crammed with facts

2016 Wellcome Trust Blog

56. Effectiveness of a group diabetes education programme in under-served communities in South Africa: a pragmatic cluster randomized controlled trial. Full Text available with Trip Pro

blood pressure, mean weight loss, mean waist circumference, mean HbA1c and mean total cholesterol levels and quality of life.A total of 422 (59.4%) participants in the intervention group did not attend any education sessions. No significant improvement was found in any of the primary or secondary outcomes, apart from a significant reduction in mean systolic (-4.65 mmHg, 95% CI 9.18 to -0.12; P = 0.04) and diastolic blood pressure (-3.30 mmHg, 95% CI -5.35 to -1.26; P = 0.002). Process evaluation (...) suggested that there were problems with finding suitable space for group education in these under-resourced settings, with patient attendance and with full adoption of a guiding style by the health promoters.The reported effectiveness of group diabetes education offered by more highly trained professionals, in well-resourced settings, was not replicated in the present study, although the reduction in participants' mean blood pressure is likely to be of clinical significance.© 2014 The Authors. Diabetic

2014 Diabetic medicine : a journal of the British Diabetic Association Controlled trial quality: uncertain

57. Interactive Education of Patients With Coronary Heart Disease

Study Type : Interventional (Clinical Trial) Actual Enrollment : 260 participants Allocation: Randomized Intervention Model: Factorial Assignment Masking: None (Open Label) Primary Purpose: Prevention Official Title: Development of Sustainable Methods in Interactive Patient Education to Improve Adherence After Cardiac Rehabilitation Study Start Date : May 2014 Actual Primary Completion Date : November 2014 Actual Study Completion Date : November 2015 Resource links provided by the National Library (...) : Training content as a measure of success [ Time Frame: 3 - 4 weeks ] Reaching a total score (70 points) with respect to the training content as a measure of success of the current interactive patient education Secondary Outcome Measures : BMI and / or abdominal circumference [ Time Frame: 12 months ] Change in BMI and / or abdominal circumference Blood Cholesterol Values [ Time Frame: 12 months ] Change in Blood Cholesterol Values Depression Score [ Time Frame: 12 months ] Change in Depression Score

2014 Clinical Trials

58. Evaluation of the Educational Program of Diabetes Mellitus: Focus on Empowerment

to Layout table for study information Study Type : Interventional (Clinical Trial) Actual Enrollment : 191 participants Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Prevention Official Title: Evaluation of the Educational Program of Diabetes Mellitus: Focus on Empowerment Study Start Date : June 2014 Estimated Primary Completion Date : June 2015 Estimated Study Completion Date : November 2017 Resource links provided by the National Library of Medicine related (...) Evaluation of the Educational Program of Diabetes Mellitus: Focus on Empowerment Evaluation of the Educational Program of Diabetes Mellitus: Focus on Empowerment - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding

2014 Clinical Trials

59. Impact of Structured Physical Activity Education Delivery in Patients With Type 2 Diabetes Mellitus

to Canadian Diabetes Association Clinical Practice Guidelines Weekly Physical Activity Recommendations for Patients With Type 2 Diabetes Mellitus: A Pilot Study. Study Start Date : April 2014 Actual Primary Completion Date : September 2015 Actual Study Completion Date : June 2016 Resource links provided by the National Library of Medicine related topics: related topics: Arms and Interventions Go to Arm Intervention/treatment Active Comparator: Unstructured Physical Activity and Exercise Education Delivery (...) , Canada, L4M 6L2 Sponsors and Collaborators Royal Victoria Hospital, Canada Investigators Layout table for investigator information Principal Investigator: Dr. Andrew Wozniak, MD, CCFP Barrie and Community Family Health Team More Information Go to Publications: J.R. Fowles, C. Shields, R.J.L. Murphy and P Dunbar. Developing Competency in Diabetes Education Volume 3: Physical Activity and Exercise Professional Resource Manual. The Canadian Diabetes Association. 2012. Toronto, Ontario. 110 pages. Sigal

2014 Clinical Trials

60. Interactive Cholesterol Advisory Tool

Go to Brief Summary: The purpose of this study is to show that we can effectively deliver health information and education, online, via computer regarding cholesterol. This computer program is called the Interactive Cholesterol Advisory Tool (ICAT). Condition or disease Intervention/treatment Phase Low Risk (0-10% Chance) of Developing Cardiovascular Disease Within 10 Years Based on Risk Factors Moderate Risk (10-20% Chance) of Developing Cardiovascular (Heart) Disease Within 10 Years Based (...) : Interventional (Clinical Trial) Actual Enrollment : 131 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking: None (Open Label) Official Title: The Interactive Cholesterol Advisory Tool Study Start Date : January 2012 Actual Primary Completion Date : June 2013 Actual Study Completion Date : June 2013 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment No Intervention: Low Risk, No ICAT Low risk

2012 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>